Employers › Lyndra Therapeutics
Recordkeeping fees per participant · Lyndra, Inc. 401(k) Plan · plan year 2024
$208.58
Higher than 90% of the 7,477 plans $1 to 10M that report it.
= $28,158 / 135
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250812095418NAL0007142243001, received 2025-08-12
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250812095418NAL0007142243001, received 2025-08-12
Percentiles compare this plan with the Schedule H plans $1 to 10M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-08-12.
Administrative expenses excluding investment management, per participant
$208.58
Higher than 79% of the 14,713 plans $1 to 10M that report it.
= $28,158 / 135
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250812095418NAL0007142243001, received 2025-08-12
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250812095418NAL0007142243001, received 2025-08-12
Administrative expenses per participant
$208.58
Higher than 64% of the 15,210 plans $1 to 10M that report it.
= $28,158 / 135
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250812095418NAL0007142243001, received 2025-08-12
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250812095418NAL0007142243001, received 2025-08-12
Administrative expenses as a share of assets
0.347%
Higher than 34% of the 15,243 plans $1 to 10M that report it.
= $28,158 / $8,111,608
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250812095418NAL0007142243001, received 2025-08-12
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250812095418NAL0007142243001, received 2025-08-12
Employer contributions per participant
$3,490
Higher than 95% of the 13,342 plans $1 to 10M that report it.
= $471,093 / 135
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250812095418NAL0007142243001, received 2025-08-12
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250812095418NAL0007142243001, received 2025-08-12
Employer share of total contributions
29.8%
Higher than 53% of the 13,370 plans $1 to 10M that report it.
= $471,093 / $1,581,909
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250812095418NAL0007142243001, received 2025-08-12
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250812095418NAL0007142243001, received 2025-08-12
Plan terms are not published in public filings.
2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 3D IRS pre-approved plan · 2T default investment (QDIA) · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20250812095418NAL0007142243001, received 2025-08-12
| Field | Value | Source |
|---|---|---|
| Plan sponsor | LYNDRA THERAPEUTICS, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Plan name | LYNDRA, INC. 401(K) PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Sponsor EIN / plan number | 47-2817157 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Sponsor location | WATERTOWN, MA | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Industry (business code) | 541990, Professional, scientific, and technical services | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Filing received | 2025-08-12 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Participants, beginning of year | 158 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Active participants | 58 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Participants, end of year | 136 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Participants with an account balance | 135 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Total assets, beginning of year | $7,332,581 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Total assets, end of year | $8,111,608 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Net assets, end of year | $8,111,608 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Total income | $2,665,611 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Net income | $779,027 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Employer contributions | $471,093 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Participant contributions | $1,015,153 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Other contributions (incl. rollovers) | $95,663 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Total contributions | $1,581,909 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Benefit payments | $1,858,426 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Total expenses (incl. benefit payments) | $1,886,584 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Total administrative expenses | $28,158 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Recordkeeping fees | $28,158 | Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Administrative expenses excluding investment management | $28,158 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Held in mutual funds | $7,924,421 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20250812095418NAL0007142243001, received 2025-08-12 |
| Independent auditor | KAHN, LITWIN, RENZA & CO., LTD. | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20250812095418NAL0007142243001, received 2025-08-12 |
Position = column in the DOL layout for form year 2024. Filing 20250812095418NAL0007142243001, received 2025-08-12.
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| T. ROWE PRICE RPS, INC.recordkeeper | NONE | 15 Recordkeeping and information management; 21 Trustee (bank, trust company or similar); 25 Trustee (directed); 28 Investment management; 37 Participant loan processing; 38 Participant communication; 49 Other services; 50 Direct payment from the plan; 52 Investment management fees paid indirectly by plan; 57 Redemption fees; 59 Shareholder servicing fees; 62 Float revenue; 63 Distribution (12b-1) fees; 64 Recordkeeping fees; 65 Account maintenance fees | $28,158 | yes |
| BLACKROCK FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| PUTNAM MUTUAL FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| AMERICAN FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| DIMENSIONAL FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| PRUDENTIAL JENNISON | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| MFS FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| FIDELITY | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| JP MORGAN FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| VOYA FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| LORD ABBETT | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20250812095418NAL0007142243001, received 2025-08-12.
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $7,332,581 | $8,111,608 | 10.6% |
| Participants with a balance | 156 | 135 | -13.5% |
| Administrative expenses | $28,565 | $28,158 | -1.4% |
| Recordkeeping fees per participant | not reported | $208.58 | |
| Employer contributions | $682,105 | $471,093 | -30.9% |
Prior filing 20241015142133NAL0014823907001, received 2024-10-15; the plan years are contiguous.
Sponsor name as filed: LYNDRA THERAPEUTICS, INC.; SEC registrant: Lyndra Therapeutics, Inc. (CIK 1679037, matched by EIN).